A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is
This concept communication describes a mass spectrometry workflow specific to biomarker assay development and validation. The primary objective of this workflow is to significantly decrease the cost and timeline for assay development and biomarker validation. The biomarker development workflow can be separated into five development stages that take less than 6 months to complete. Figure 5: Absolute quantitation assay scheme. Panel A) Typical chromatographic data for native peptides and theirdoi:10.4172/jpb.1000448 fatcat:npa4moxwqbfudlooostpwyg74q